NO20072794L - Kjemiske forbindelser - Google Patents
Kjemiske forbindelserInfo
- Publication number
- NO20072794L NO20072794L NO20072794A NO20072794A NO20072794L NO 20072794 L NO20072794 L NO 20072794L NO 20072794 A NO20072794 A NO 20072794A NO 20072794 A NO20072794 A NO 20072794A NO 20072794 L NO20072794 L NO 20072794L
- Authority
- NO
- Norway
- Prior art keywords
- chemical connections
- sarsasapogenin
- connections
- chemical
- solvated
- Prior art date
Links
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 abstract 4
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0424528A GB0424528D0 (en) | 2004-11-05 | 2004-11-05 | Chemical compounds |
| PCT/GB2005/004266 WO2006048665A2 (fr) | 2004-11-05 | 2005-11-04 | Composes chimiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072794L true NO20072794L (no) | 2007-07-31 |
Family
ID=33523268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072794A NO20072794L (no) | 2004-11-05 | 2007-06-01 | Kjemiske forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080194530A1 (fr) |
| EP (2) | EP1809650A2 (fr) |
| JP (1) | JP2008519020A (fr) |
| KR (1) | KR20070089798A (fr) |
| CN (2) | CN102219826A (fr) |
| AU (1) | AU2005300348A1 (fr) |
| BR (1) | BRPI0517648A (fr) |
| CA (1) | CA2584676A1 (fr) |
| GB (1) | GB0424528D0 (fr) |
| IL (1) | IL182879A0 (fr) |
| MX (1) | MX2007005473A (fr) |
| NO (1) | NO20072794L (fr) |
| RU (1) | RU2007119611A (fr) |
| SG (1) | SG158068A1 (fr) |
| TW (1) | TW200635941A (fr) |
| WO (1) | WO2006048665A2 (fr) |
| ZA (1) | ZA200703630B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201190115A1 (ru) | 2009-01-24 | 2012-02-28 | ФИТОФАРМ ПиЭлСи | Лечение расстройств, опосредованных нейротрофическим фактором |
| KR20130043197A (ko) | 2010-07-20 | 2013-04-29 | 파이토팜 피엘씨 | 엘-도파, 도파민 효능제 및/또는 도파민 증강제 유도된 장애의 치료 |
| JP5881525B2 (ja) * | 2011-05-16 | 2016-03-09 | ライオン株式会社 | サポゲニン安定化組成物の製造方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2306635A (en) * | 1940-08-03 | 1942-12-29 | Parke Davis & Co | Method for the preparation of steroidal carbinols |
| US2408827A (en) * | 1944-05-15 | 1946-10-08 | Parke Davis & Co | Steroidal compounds and methods for obtaining the same |
| US2774714A (en) * | 1952-10-10 | 1956-12-18 | Emanuel B Hershberg | Process for the extraction of sapogenins from plant materials |
| US3019220A (en) * | 1958-07-17 | 1962-01-30 | Julian Lab Inc | Isolation of sapogenins |
| US4057543A (en) * | 1976-07-01 | 1977-11-08 | G. D. Searle & Co. | Process for the preparation of 17β-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone |
| US4680289A (en) * | 1985-06-05 | 1987-07-14 | Progenics, Inc. | Treatment of obesity and diabetes using sapogenins |
| JPH04230696A (ja) * | 1990-12-28 | 1992-08-19 | Sanwa Shiyouyaku Kk | 新規なステロイド系化合物および制癌剤 |
| CN1033754C (zh) * | 1993-05-31 | 1997-01-08 | 上海第二医科大学 | 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法 |
| KR100217996B1 (ko) * | 1996-12-23 | 1999-09-01 | 윤종용 | 프린트 헤드의 노즐 간격 보상 장치 및 방법 |
| DK1066042T3 (da) | 1998-03-26 | 2006-12-18 | Phytopharm Plc | Steroidale saponiner til behandling af Alzheimers sygdom |
| GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
| AT409100B (de) | 2000-07-24 | 2002-05-27 | Evg Entwicklung Verwert Ges | Vorrichtung zum schweissen einer drahtgittermatte |
| GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
| WO2003082893A2 (fr) * | 2002-03-27 | 2003-10-09 | Phytopharm Plc | Methodes therapeutiques et utilisations des sapogenines et de leurs derives |
-
2004
- 2004-11-05 GB GB0424528A patent/GB0424528D0/en not_active Ceased
-
2005
- 2005-11-04 WO PCT/GB2005/004266 patent/WO2006048665A2/fr not_active Ceased
- 2005-11-04 JP JP2007539637A patent/JP2008519020A/ja active Pending
- 2005-11-04 SG SG200907351-1A patent/SG158068A1/en unknown
- 2005-11-04 US US11/667,035 patent/US20080194530A1/en not_active Abandoned
- 2005-11-04 CA CA002584676A patent/CA2584676A1/fr not_active Abandoned
- 2005-11-04 CN CN2011100921741A patent/CN102219826A/zh active Pending
- 2005-11-04 BR BRPI0517648-4A patent/BRPI0517648A/pt not_active IP Right Cessation
- 2005-11-04 AU AU2005300348A patent/AU2005300348A1/en not_active Abandoned
- 2005-11-04 RU RU2007119611/04A patent/RU2007119611A/ru not_active Application Discontinuation
- 2005-11-04 KR KR1020077012720A patent/KR20070089798A/ko not_active Withdrawn
- 2005-11-04 EP EP05799915A patent/EP1809650A2/fr not_active Withdrawn
- 2005-11-04 CN CN200580037705XA patent/CN101068827B/zh not_active Expired - Fee Related
- 2005-11-04 TW TW094138749A patent/TW200635941A/zh unknown
- 2005-11-04 MX MX2007005473A patent/MX2007005473A/es unknown
- 2005-11-04 EP EP11155897.9A patent/EP2479183A3/fr not_active Withdrawn
-
2007
- 2007-04-30 IL IL182879A patent/IL182879A0/en unknown
- 2007-05-04 ZA ZA200703630A patent/ZA200703630B/xx unknown
- 2007-06-01 NO NO20072794A patent/NO20072794L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SG158068A1 (en) | 2010-01-29 |
| RU2007119611A (ru) | 2008-12-10 |
| GB0424528D0 (en) | 2004-12-08 |
| CN101068827B (zh) | 2011-06-08 |
| IL182879A0 (en) | 2007-08-19 |
| WO2006048665A2 (fr) | 2006-05-11 |
| EP1809650A2 (fr) | 2007-07-25 |
| CN102219826A (zh) | 2011-10-19 |
| EP2479183A3 (fr) | 2013-08-28 |
| KR20070089798A (ko) | 2007-09-03 |
| US20080194530A1 (en) | 2008-08-14 |
| WO2006048665A3 (fr) | 2006-09-08 |
| AU2005300348A1 (en) | 2006-05-11 |
| BRPI0517648A (pt) | 2008-10-14 |
| JP2008519020A (ja) | 2008-06-05 |
| EP2479183A2 (fr) | 2012-07-25 |
| ZA200703630B (en) | 2009-10-28 |
| CA2584676A1 (fr) | 2006-05-11 |
| TW200635941A (en) | 2006-10-16 |
| CN101068827A (zh) | 2007-11-07 |
| MX2007005473A (es) | 2007-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| IL211084A0 (en) | Single use module | |
| NO20080010L (no) | GPCR-agonister | |
| NO20055204D0 (no) | Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi | |
| IS8074A (is) | Setin 1,4- Díazepín og notkun theirra | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| NO20051503D0 (no) | Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme. | |
| ATE393764T1 (de) | Polymorphe formen von valsartan | |
| NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
| DK1581518T3 (da) | Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister | |
| DK2561880T3 (da) | Mælkesyrebakterier som priobiotiske stammer og sammensætninger dermed | |
| NO20072005L (no) | Nye heterocykliske amider | |
| NO20044898L (no) | Nye etonogestrel estere | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| NO20050063L (no) | 2-heteroaryl karboksamider | |
| DE502004005907D1 (de) | Selbstemulgierende wässrige polyurethandispersionen | |
| NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer | |
| IS7883A (is) | Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau | |
| IS8220A (is) | Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun | |
| NO20072794L (no) | Kjemiske forbindelser | |
| IS7980A (is) | Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun | |
| WO2007025146A3 (fr) | Preparations de balsalazide, leur procede d'obtention et leurs utilisations | |
| NO20065485L (no) | Kjemiske forbindelser | |
| ATE499095T1 (de) | Wässrige olanexidin-lösung, herstellungsverfahren dafür und desinfektionsmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |